• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源单克隆抗体对严重急性呼吸综合征冠状病毒2核衣壳RNA结合结构域的表位识别

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies.

作者信息

Kim Youngchang, Maltseva Natalia, Tesar Christine, Jedrzejczak Robert, Endres Michael, Ma Heng, Dugan Haley L, Stamper Christopher T, Chang Changsoo, Li Lei, Changrob Siriruk, Zheng Nai-Ying, Huang Min, Ramanathan Arvind, Wilson Patrick, Michalska Karolina, Joachimiak Andrzej

机构信息

Center for Structural Biology of Infectious Diseases, Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL 60367, USA.

Structural Biology Center, X-ray Science Division, Argonne National Laboratory, Lemont, IL 60439, USA.

出版信息

iScience. 2024 Jan 19;27(2):108976. doi: 10.1016/j.isci.2024.108976. eCollection 2024 Feb 16.

DOI:10.1016/j.isci.2024.108976
PMID:38327783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10847736/
Abstract

Coronavirus nucleocapsid protein (NP) of SARS-CoV-2 plays a central role in many functions important for virus proliferation including packaging and protecting genomic RNA. The protein shares sequence, structure, and architecture with nucleocapsid proteins from betacoronaviruses. The N-terminal domain (NP) binds RNA and the C-terminal domain is responsible for dimerization. After infection, NP is highly expressed and triggers robust host immune response. The anti-NP antibodies are not protective and not neutralizing but can effectively detect viral proliferation soon after infection. Two structures of SARS-CoV-2 NP were determined providing a continuous model from residue 48 to 173, including RNA binding region and key epitopes. Five structures of NP complexes with human mAbs were isolated using an antigen-bait sorting. Complexes revealed a distinct complement-determining regions and unique sets of epitope recognition. This may assist in the early detection of pathogens and designing peptide-based vaccines. Mutations that significantly increase viral load were mapped on developed, full length NP model, likely impacting interactions with host proteins and viral RNA.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的冠状病毒核衣壳蛋白(NP)在病毒增殖的许多重要功能中发挥核心作用,包括包装和保护基因组RNA。该蛋白与β冠状病毒的核衣壳蛋白具有序列、结构和构象上的相似性。N端结构域(NP)结合RNA,C端结构域负责二聚化。感染后,NP高度表达并引发强烈的宿主免疫反应。抗NP抗体不具有保护作用和中和作用,但能在感染后不久有效检测病毒增殖。确定了SARS-CoV-2 NP的两种结构,提供了从第48位残基到第173位残基的连续模型,包括RNA结合区域和关键表位。使用抗原诱饵分选法分离出NP与人单克隆抗体复合物的五种结构。复合物显示出独特的互补决定区和独特的表位识别集。这可能有助于病原体的早期检测和基于肽的疫苗设计。在构建的全长NP模型上定位了显著增加病毒载量的突变,这些突变可能影响与宿主蛋白和病毒RNA的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/d2d66cee9959/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/f14bf84bd7c7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/f37c66088968/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/0ff985765147/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/3df7fcbb5344/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/5604ec9037eb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/a1313a6c64f1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/d2d66cee9959/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/f14bf84bd7c7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/f37c66088968/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/0ff985765147/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/3df7fcbb5344/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/5604ec9037eb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/a1313a6c64f1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4c8/10847736/d2d66cee9959/gr6.jpg

相似文献

1
Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies.人源单克隆抗体对严重急性呼吸综合征冠状病毒2核衣壳RNA结合结构域的表位识别
iScience. 2024 Jan 19;27(2):108976. doi: 10.1016/j.isci.2024.108976. eCollection 2024 Feb 16.
2
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.重组杆状病毒表达的严重急性呼吸综合征冠状病毒刺突蛋白的抗原性和免疫原性特征:对疫苗设计的启示
J Virol. 2006 Jun;80(12):5757-67. doi: 10.1128/JVI.00083-06.
3
Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.人类针对 SARS-CoV-2 刺突蛋白受体结合域的中和抗体的结构基础。
Microbiol Spectr. 2021 Oct 31;9(2):e0135221. doi: 10.1128/Spectrum.01352-21. Epub 2021 Oct 13.
4
Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses.针对严重急性呼吸综合征冠状病毒-2 核衣壳蛋白 N 端和 C 端结构域的患者源性单克隆抗体与严重急性呼吸综合征冠状病毒的相应抗体发生交叉反应,但与其他人类β冠状病毒不发生反应。
Front Immunol. 2023 Jan 31;14:1093709. doi: 10.3389/fimmu.2023.1093709. eCollection 2023.
5
Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.新型冠状病毒刺突蛋白受体结合域中新型中和表位的鉴定与表征:揭示灭活新型冠状病毒疫苗中的关键抗原决定簇
Vaccine. 2006 Jun 29;24(26):5498-508. doi: 10.1016/j.vaccine.2006.04.054. Epub 2006 May 11.
6
Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients.鉴定伊朗 COVID-19 患者体内 SARS-CoV-2 的核衣壳蛋白和刺突蛋白上的免疫优势表位。
Pathog Dis. 2022 Feb 9;80(1). doi: 10.1093/femspd/ftac001.
7
Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses.严重急性呼吸综合征和229E型人冠状病毒核衣壳蛋白的生化与免疫学研究
Proteomics. 2005 Mar;5(4):925-37. doi: 10.1002/pmic.200401204.
8
Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.使用识别保守核衣壳蛋白表位的特异性单克隆抗体的新型冠状病毒快速生物传感器
Viruses. 2022 Jan 27;14(2):255. doi: 10.3390/v14020255.
9
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.与严重急性呼吸综合征冠状病毒刺突蛋白和核衣壳蛋白结合的人单克隆抗体的分子和生物学特性
J Virol. 2005 Feb;79(3):1635-44. doi: 10.1128/JVI.79.3.1635-1644.2005.
10
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.

引用本文的文献

1
Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA.严重急性呼吸综合征冠状病毒2核蛋白的无亲和标签纯化及其与单链DNA复合物的晶体结构
Biomolecules. 2024 Nov 30;14(12):1538. doi: 10.3390/biom14121538.

本文引用的文献

1
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual.源自一名感染伽马冠状病毒个体的单克隆抗体和双特异性抗体对严重急性呼吸综合征冠状病毒2具有广泛中和作用。
iScience. 2023 Sep 22;26(10):108009. doi: 10.1016/j.isci.2023.108009. eCollection 2023 Oct 20.
2
An interoperable implementation of collective-variable based enhanced sampling methods in extended phase space within the OpenMM package.在OpenMM软件包中扩展相空间内基于集体变量的增强采样方法的可互操作实现。
J Comput Chem. 2023 Oct 30;44(28):2166-2183. doi: 10.1002/jcc.27182. Epub 2023 Jul 18.
3
Serodominant SARS-CoV-2 Nucleocapsid Peptides Map to Unstructured Protein Regions.
优势血清型 SARS-CoV-2 核衣壳肽映射到无规卷曲蛋白区域。
Microbiol Spectr. 2023 Jun 15;11(3):e0032423. doi: 10.1128/spectrum.00324-23. Epub 2023 May 16.
4
Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants.鉴定核衣壳(N)蛋白中的 B 细胞线性表位 主要 SARS-CoV-2 变体中保守的 B 细胞线性表位。
Viruses. 2023 Apr 6;15(4):923. doi: 10.3390/v15040923.
5
Crystal structure of the membrane (M) protein from a bat betacoronavirus.一种蝙蝠β冠状病毒膜(M)蛋白的晶体结构
PNAS Nexus. 2023 Jan 30;2(2):pgad021. doi: 10.1093/pnasnexus/pgad021. eCollection 2023 Feb.
6
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.SARS-CoV-2 突变:结构、变体、疫苗和生物医学干预的洞察。
Biomed Pharmacother. 2023 Jan;157:113977. doi: 10.1016/j.biopha.2022.113977. Epub 2022 Nov 7.
7
The Spike Mutants Website: A Worldwide Used Resource against SARS-CoV-2.刺突突变株网站:全球用于对抗 SARS-CoV-2 的资源
Int J Mol Sci. 2022 Oct 28;23(21):13082. doi: 10.3390/ijms232113082.
8
Covid-19: Early Cases and Disease Spread.新型冠状病毒肺炎:早期病例与疾病传播。
Ann Glob Health. 2022 Sep 29;88(1):83. doi: 10.5334/aogh.3776. eCollection 2022.
9
Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2.天然发生的刺突突变影响 SARS-CoV-2 的感染性和免疫原性。
Cell Mol Immunol. 2022 Nov;19(11):1302-1310. doi: 10.1038/s41423-022-00924-8. Epub 2022 Oct 12.
10
The origins of COVID-19 pandemic: A brief overview.新冠疫情的起源:简要概述。
Transbound Emerg Dis. 2022 Nov;69(6):3181-3197. doi: 10.1111/tbed.14732. Epub 2022 Oct 20.